CDH1 and hepatocellular carcinoma: Studies also indicated that sorafenib resistant HCC cells showed EMT characteristics with the downregulation of epithelial marker (N-Cadherin and Vimentin) and upregulation of mesenchymal makers (E-Cadherin) [65].